Chemoinformaics analysis of Macarangioside D
| Molecular Weight | 386.441 | nRot | 6 |
| Heavy Atom Molecular Weight | 356.201 | nRig | 15 |
| Exact Molecular Weight | 386.194 | nRing | 2 |
| Solubility: LogS | -1.518 | nHRing | 1 |
| Solubility: LogP | 0.078 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 58.1498 |
| nHD | 5 | BPOL | 34.4362 |
| QED | 0.357 |
| Synth | 4.933 |
| Natural Product Likeliness | 2.366 |
| NR-PPAR-gamma | 0.211 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.049 |
| Pgp-sub | 0.394 |
| HIA | 0.868 |
| CACO-2 | -5.073 |
| MDCK | 0.000142096 |
| BBB | 0.203 |
| PPB | 0.319533 |
| VDSS | 0.409 |
| FU | 0.822413 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.069 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.239 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.143 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.136 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.14 |
| CL | 3.521 |
| T12 | 0.85 |
| hERG | 0.016 |
| Ames | 0.498 |
| ROA | 0.024 |
| SkinSen | 0.266 |
| Carcinogencity | 0.041 |
| EI | 0.022 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.023 |
| Antiviral | Yes |
| Prediction | 0.734428 |